AHCO vs INCY · P/E 16, rev $1.42B vs P/E 14, rev $5.14B
Adapthealth Corp (AHCO) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Adapthealth Corp (AHCO) is a medical devices company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported AHCO revenue for 2026-06-30 was $1.42B. Net income was -$150.0M. Revenue was up 73.2% from 2026-03-31 to 2026-06-30. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the AHCO and INCY stock pages for the full models.
Not investment advice.